Divi's Labs Q4 net profit plunges 64% YoY; Here's what brokerages say
Divi's Labs' Q4 earnings missed estimates but reflected improvement on a sequential basis.
Source: moneycontrol.com
Stay updated with breaking news from Pharma Sector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Divi's Labs' Q4 earnings missed estimates but reflected improvement on a sequential basis.
Analysts had pegged a net profit of Rs 373.30 crore for Divi's Laboratories.
Excluding the one-time loss of Rs 601.30 crore, Zydus Lifesciences would have clocked a net profit of Rs 897.9 crore, which is well ahead of the Street's estimate.
An update by Cipla's management that key drug launches will now be delayed by around 12 months have prompted a slew of earnings downgrades for FY24.
Dr Reddy's bottomline also lagged the Street's estimate of Rs 1,093.6 crore.